The Minnesota Department of Human Services (DHS) released the report in January 2017. It presents the findings of the DHS Alcohol and Drug Abuse Division evaluation of the impact of Institutions of Mental Disease (IMD) changes in 2016 on treatment admissions in Minnesota. In 2015, an internal review raised concerns about how DHS has determined the eligibility of some chemical dependency treatment programs for Medicaid reimbursement. The federal Medicaid program defines an IMD as any facility with 16 or more beds are for psychiatric or addiction treatment, or a residential facility of 16 or more beds in which more than . . .